A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin

被引：0
|
作者：
Qi, Yu
Yang, Yang
Li, Weihao
Yue, Songwei
Ma, Yihui
Liu, Donglei
He, Zhanfeng
Chen, Lidong
Li, Wencai
Li, Linghua
Zhao, Song
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Zhengzhou, Peoples R China
[3] Jiangsu Hengrui Med Co Ltd, Lianyungang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16075
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
    Lu, Zhihao
    Zhang, Yanqiao
    Fan, Qingxia
    Pan, Yueyin
    Jiang, Da
    Lu, Ping
    Zhang, Jingdong
    Yuan, Xianglin
    Feng, Jifeng
    Yang, Shujun
    Yue, Wenbin
    Zhao, Lin
    Xu, Yunhua
    Luo, Jinhua
    Shen, Lin
    INNOVATION, 2022, 3 (03):
  • [42] A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient A case report
    Fang, Yueyu
    Sun, Hui
    Chen, Yi
    Jiang, Nanyuan
    Ji, Lianhua
    Shi, Junfeng
    MEDICINE, 2021, 100 (31) : E26801
  • [43] Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
    Song, Qi
    Wang, Herui
    Jiang, Dongxian
    Xu, Chen
    Cui, Jing
    Zhang, Qi
    Wang, Haixing
    Huang, Jie
    Su, Jieakesu
    Wu, Gen Sheng
    Zhuang, Zhengping
    Hou, Yingyong
    CANCERS, 2021, 13 (19)
  • [44] Anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial
    Chang, Zhiwei
    Liu, Xiao-Lei
    Yu, Dan-Dan
    Han, Hui-Qiong
    He, Jian
    Wang, Rui-Rui
    Qin, Yan-ru
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 340 - 340
  • [45] A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer
    Wu, Kan
    Zhu, Lucheng
    Wang, Jiahao
    Pan, Kaicheng
    Wang, Bing
    Li, Xin
    Yang, Shaoyu
    Xu, Xiao
    Zhang, Minna
    Li, Xiadong
    Chen, Xueqin
    Ma, Shenglin
    Xia, Bing
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4529 - 4537
  • [46] Randomized phase II trial of carboplatin plus nab-paclitaxel versus cisplatin plus gemcitabine for chemotherapy-naive squamous cell carcinoma: North Japan lung cancer study group 1302
    Kawashima, Yosuke
    Harada, Toshiyuki
    Fujita, Yuka
    Nakagawa, Taku
    Watanabe, Kana
    Morikawa, Naoto
    Takamura, Kei
    Kanazawa, Kenya
    Kuda, Tomoya
    Usui, Kazuhiro
    Sekine, Akimasa
    Inoue, Akira
    Sugawara, Shunichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 515 - 522
  • [47] Combined modality treatment of the esophageal squamous cell carcinoma
    Kopacz, A
    Jaskiewicz, J
    Jastrzebski, T
    Kruszewski, W
    Swierblewski, M
    Kucharski, A
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 517 - 521
  • [48] Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma
    Sheth, Siddharth
    Gilbert, Jill
    Deal, Allison Mary
    Chera, Bhishamjit
    Murphy, Barbara
    Woods, Justin
    Miller, Kelsey
    Weissler, Mark
    Hackman, Trevor
    Liao, Jay Justin
    Olson, Juneko Grilley
    Hayes, David Neil
    Weiss, Jared
    ORAL ONCOLOGY, 2022, 127
  • [49] Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
    Lin, Chia-Chi
    Yeh, Kun-Huei
    Yang, Chih-Hsin
    Hsu, Chiun
    Tsai, Yu-Chieh
    Hsu, Wei-Ling
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    ANTI-CANCER DRUGS, 2007, 18 (06) : 703 - 708
  • [50] nab-Paclitaxel for the Treatment of Advanced Squamous Non-Small-Cell Lung Cancer: A Comprehensive Update
    Simon, George R.
    CLINICAL LUNG CANCER, 2014, 15 (06) : 391 - 397
12345